Navignostics AG hat dies direkt geteilt
Do you know that cancer treatment is never a one-size-fits-all approach for patients? In this Sejelas Founder-CEO Interview series, we hear from Dr. Jana Fischer, the Co-Founder and CEO at Navignostics AG. The team specialises in spatial single-cell proteomic tumour analysis for better cancer treatment. Read the full article here: https://lnkd.in/gcbhATci #diagnostics #cancer #tumour #lifescience #sejelas #founderceo #interviewseries